Effects of a Psychotherapy Group Program for Children and Adolescents With Post-traumatic Stress Symptoms
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 80
- 试验地点
- 3
- 主要终点
- Change of Therapy Motivation of children and adolescents from baseline to four weeks after treatment.
研究概览
简要总结
The study aims to investigate how the inclusion of an animal into a trauma-focused group therapy program (TF-CBT) affects therapy motivation of children and adolescents suffering from post-traumatic stress. 80 children and adolescents aged 9 to 17 years are recruited for the study. Participants must have experienced at least one traumatic event leading to post-traumatic stress symptoms. Participants are randomly allocated to one of two groups: animal-assisted trauma-focused therapy (AA TF-CBT) or standard trauma-focused therapy (TF-CBT). Parallel to the groups the parents/guardians of the participating children and adolescents take part in three parent meetings.
The results of the study help to gain insights into how the inclusion of animals in trauma-focused psychotherapy can contribute to children and adolescents attending therapy, being more motivated in therapy, and can successfully complete therapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 9 Years 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age between 9 and 17 years
- •experienced a traumatic event
- •remembers at least one traumatic event
- •Suffering from posttraumatic stress symptoms (screened via the CATS-2; cut-off ≥ 21; cut-off must be reached by either participant or caregiver)
- •Basic knowledge of child and parents in German to be able to understand content of the session and to fill in questionnaires
- •Informed consent (given by legal guardian for participants younger than 14 years)
- •Positive or neutral attitude towards animals
排除标准
- •Inability to complete questionnaires due to lack of language skills or cognitive impairment
- •Diagnosed autism spectrum disorder; Exclusion only if interaction with others and group ability is limited due to autism
- •Reported significant impairment or safety issue (e.g., active suicidal ideation, acute psychosis)
- •Known abuse of substances used for emotion regulation (e.g. cannabis, alcohol, other hard drugs)
- •Fear of domestic animals
- •Allergic reactions to domestic animals
- •Reported aggressive behavior towards animals in the past
结局指标
主要结局
Change of Therapy Motivation of children and adolescents from baseline to four weeks after treatment.
时间窗: before treatment (baseline), after 10 weeks of treatment (post-measurement), four weeks after treatment (follow-up)
Therapy motivation is assessed using the validated Situational Motivation Scale for Children (SMS-15, Skalski, 2019). The SMS-15 consists of 15 items answered with a 7 point likert scale. The total score equals the ratings of the 15 items on the scale. Higher scores mean a better outcome (increased motivation), lower scores mean a worse outcome (decreased motivation). The questionnaire assesses the motivation from the perception of the child.
次要结局
- Change of PTSD symptoms of children and adolescents from baseline to four weeks after treatment.(before treatment (baseline), after ten weeks of treatment (post-measurement), four weeks after treatment (follow-up))
- Change of Quality of Life of children and adolescents from baseline to four weeks after treatment.(before treatment (baseline), after ten weeks of treatment (post-measurement), four weeks after treatment (follow-up))
- Change of Self-efficacy of children and adolescents from baseline to four weeks after treatment.(before treatment (baseline), after ten weeks of treatment (post-measurement), four weeks after treatment (follow-up))
- Change of Therapeutic alliance of children and adolescents from baseline to four weeks after treatment.(before treatment (baseline), after ten weeks of treatment (post-measurement), four weeks after treatment (follow-up))
- Qualitative assessment of participants' perception of the group therapy at follow-up.(four weeks after treatment at follow-up)
研究者
Dr. Karin Hediger
Prof. Dr.
University of Basel